Contineum Therapeutics (CTNM) EBT (2023 - 2026)
Contineum Therapeutics (CTNM) posted quarterly EBT of -$56.8 million for Q2 2026, down 149.44% year-over-year from $114.8 million in Q2 2025, and down 36.94% quarter-over-quarter from -$41.5 million in Q1 2026.
Contineum Therapeutics (CTNM) EBT (2023 - 2026) Analysis & Trends
Contineum Therapeutics' EBT history runs 4 years deep, the most recent figure standing at -$56.8 million for Q2 2026.
- In Q2 2026, EBT fell 149.44% year-over-year to -$56.8 million; the TTM figure through Jun 2026 stood at -$147.0 million (down 101.76% YoY), while the FY2025 annual figure was -$107.8 million, down 155.13% from the prior year.
- EBT for Q2 2026 stood at -$56.8 million, down from -$41.5 million in the prior quarter.
- The five-year high for EBT was $42.3 million in Q2 2023, with the low at -$56.8 million in Q2 2026.
- The 4-year median for EBT is -$12.4 million (2024), against an average of -$15.3 million.
- Peak annual rise in EBT reached 9.56% in 2025, while the deepest fall reached 219.79% in 2025.
- Contineum Therapeutics' EBT stood at -$7.9 million in 2023, then plunged by 83.67% to -$14.6 million in 2024, then retreated by 9.56% to -$16.0 million in 2025, then tumbled by 255.81% to -$56.8 million in 2026.
- Business Quant data shows CTNM's EBT at -$56.8 million in Q2 2026, -$41.5 million in Q1 2026, and -$16.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Contineum Therapeutics | 533.73 Mn | 533.73 Mn | - | -56.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -56.78 Mn |
| Mar 31, 2026 | -38.45 Mn |
| Dec 31, 2025 | -24.02 Mn |
| Sep 30, 2025 | -34.67 Mn |
| Jun 30, 2025 | -20.83 Mn |
| Mar 31, 2025 | -21.77 Mn |
| Dec 31, 2024 | -14.57 Mn |
| Sep 30, 2024 | -10.27 Mn |
| Jun 30, 2024 | -9.01 Mn |
| Mar 31, 2024 | -8.42 Mn |
| Dec 31, 2023 | -7.93 Mn |
| Sep 30, 2023 | -6.37 Mn |
| Jun 30, 2023 | 42.30 Mn |
| Mar 31, 2023 | -4.82 Mn |